August 2017 Archive
Gliknik Announces Dosing of First Patient in Phase 2 Trial Targeting Prevention of Recurrence of High-Risk Oral Cavity Cancer
Monday, August 28, 2017
Gliknik Inc. today announced that clinicians have enrolled and dosed the first of 80 patients in the company’s phase 2 clinical trial.
Tuesday, August 15, 2017
Read an article about USM gaining momentum via Global University Venturing.
Technical.ly Baltimore: David Wise Named Director of University System of Maryland’s Early-Stage Investment Fund
Friday, August 11, 2017
The University System of Maryland was recently named a leader for its early stage investment fund that is seeking to back early-stage startups.